Vitamin D Receptor Gene Polymorphisms and Prognosis of Breast Cancer among African-American and Hispanic Women
PLoS ONE 8(3): e57967. doi:10.1371/journal.pone.0057967
Dhruva K. Mishra, Yanyuan Wu, Marianna Sarkissyan, Suren Sarkissyan, Zujian Chen, Xiying Shang, May Ong, David Heber, H. Phillip Koeffler, Jaydutt V. Vadgama
Background: Vitamin D plays a role in cancer development and acts through the vitamin D receptor (VDR). Although African-Americans have the lowest levels of serum vitamin D, there is a dearth of information on VDR gene polymorphisms and breast cancer among African-Americans and Hispanics. This study examines whether VDR gene polymorphisms are associated with breast cancer in these cohorts.
Methods: Blood was collected from 232 breast cancer patients (Cases) and 349 non-cancer subjects (Controls).
Genotyping for four polymorphic variants of VDR (FokI, BsmI, TaqI and ApaI) was performed using the PCR-RFLP method.
Results: An increased association of the VDR-Fok1 f allele with breast cancer was observed in African-Americans (OR = 1.9, p = 0.07). Furthermore, the FbTA, FbtA and fbtA haplotypes were associated with breast cancer among African-Americans (p<0.05). Latinas were more likely to have the VDR-ApaI alleles (Aa or aa) (p = 0.008). The VDR-ApaI aa genotype was significantly associated with poorly-differentiated breast tumors (p = 0.04) in combined Cases. Kaplan-Meier survival analysis showed decreased 5-year disease-free-survival (DFS) in breast cancer patients who had the VDR-Fok1 FF genotype (p<0.05). The Cox regression with multivariate analysis revealed the independent predictor value of the VDR-FokI polymorphism for DFS. The other three variants of VDR (BsmI, TaqI and ApaI) were not associated with disease outcome.
Conclusions: VDR haplotypes are associated with breast cancer in African-Americans, but not in Hispanic/Latinas.
The VDR-FokI FF genotype is linked with poor prognosis in African-American women with breast cancer.
Received: November 5, 2012; Accepted: January 29, 2013; Published: March 12, 2013
Funding: This work was supported by National Institutes of Health(NIH)/NCI (Grant numbers U56CA101599-01; CA15083-25S3; U54CA14393); NIH/NIDDK (Grant number R25DK067015-01); Department of Defense (BCRP) (Grant number BC043180) – to JVV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Note: more graphs in the PDF
PDF is attached at the bottom of this page
Suspect that Caucasian women with these VDR genes would need more vitamin D in blood stream to prevent breast cancer.
- Vitamin D level can be high, but little benefit: due to kidney, genes, low Magnesium etc.
- Vitamin D receptor gene associated with 50 percent more type 2 Diabetes – meta-analyses 2013, 2016
- All items in category Breast Cancer and Vitamin D
- Overview Breast Cancer and Vitamin D
Items in both categories Breast Cancer and Vitamin D Receptor are listed here:
Vitamin D receptor in breasts and breast cancer vary with race – March 2013
- Some breast cancers may be treated RNA changes caused by Vitamin D – March 2022
- Breast Cancer, Vitamin D, and genes – Welsh Nov 2021
- After lactation Vitamin D levels are low, increased risk of Breast Cancer, vitamin D should decrease risk – Aug 2021
- Breasts process Vitamin D and change gene activation, might prevent breast cancer if given more Vit. D – July 2021
- Breast cancer associated with Vitamin D Receptor (14th study) – Oct 2019
- After breast cancer treatment 4,000 IU of Vitamin D was not enough to help if have poor Vitamin D receptor – June 2019
- Breast Cancer death 1.8 X more likely if poor Vitamin D Receptor – April 2019
- Breast Cancer and Vitamin D review – March 2018
- Women with Breast Cancer were 16.9 times more likely to have a poor Vitamin D Receptor – Jan 2019
- Cancer treatment by Vitamin D sometimes is restricted by genes – Oct 2018
- Two chemicals increase the Vitamin D receptor and decrease the growth of breast cancer cells in the lab - March 2018
- Breast Cancer reduces receptor and thus blocks Vitamin D to the cells – several studies
- Vitamin D receptor as a target for breast cancer therapy (abstract only) – Feb 2017
- Breast Cancer was 4.6 times more likely if have a poor Vitamin D Receptor – Dec 2016
- Increased Breast Cancer metastasis if low vitamin D or poor VDR – Feb 2016
- Increased risk of some female cancers if low vitamin D (due to genes) – meta-analysis June 2015
- Vitamin D receptor in breasts and breast cancer vary with race – March 2013
- Breast Cancer incidence change by 40 percent with vitamin D receptor genes – Oct 2012
- Genes breast cancer and vitamin D receptor - Sept 2010
6168 visitors, last modified 07 Dec, 2019,This page is in the following categories (# of items in each category)